Diabetes 51:3376-3383, 2002
© 2002 by the American Diabetes Association, Inc.
Marked Heterogeneity of Human Skeletal Muscle Lipolysis at Rest
Eva Hagström-Toft1,
Veronica Qvisth1,
Inger Nennesmo2,
Mikael Rydén1,
Helene Bolinder3,
Staffan Enoksson1,
Jan Bolinder1, and
Peter Arner1
1 Department of Medicine, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
2 Department of Pathology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden
3 Department of Rheumatology, Karolinska Hospital, Stockholm, Sweden
In this study, variations in lipolysis among different muscle groups were examined by measuring local net glycerol release in vivo in healthy, normal-weight subjects (n = 11) during rested, postabsorptive conditions. Microdialysis of the gastrocnemius, deltoid, and vastus lateralis muscle regions revealed that extracellular glycerol concentrations of these three muscle regions were 84.7 ± 6.7, 59.7 + 7.3, and 56.4 ± 7.5 µmol/l, respectively, and the arterial plasma glycerol concentration was 44.8 ± 2.3 µmol/l (P = 0.00030.006, gastrocnemius vs. others). Local tissue blood flow, as measured by Xe clearance, did not differ among the regions. Net glycerol release was significantly higher in gastrocnemius muscle than in the two other regions. There were no regional differences in glycerol uptake when studied during glycerol infusion. Gastrocnemius muscle showed a dominance of type 1 fibers (70%), whereas the vastus lateralis muscle had equal distribution of fiber types (P = 0.02). No differences in intramuscular triaclyceride content, perimuscular fat, or the adipocyte-specific protein perilipin were observed among the muscle regions. Triglyceride turnover in the gastrocnemius muscle was 3.3 + 1.4% over 24 h, which is about 10 times more rapid than the turnover rate in subcutaneous adipose tissue (P < 0.01). Thus there were marked differences in lipolytic activity among skeletal muscle groups at rest, possibly reflecting variations in fiber type.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. W.E. Jocken, C. Roepstorff, G. H. Goossens, P. van der Baan, M. van Baak, W. H.M. Saris, B. Kiens, and E. E. Blaak
Hormone-Sensitive Lipase Serine Phosphorylation and Glycerol Exchange Across Skeletal Muscle in Lean and Obese Subjects: Effect of {beta}-Adrenergic Stimulation
Diabetes,
July 1, 2008;
57(7):
1834 - 1841.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Reynolds IV, M. A. Supiano, and D. R. Dengel
Regional differences in glucose clearance: effects of insulin and resistance training on arm and leg glucose clearance in older hypertensive individuals
J Appl Physiol,
March 1, 2007;
102(3):
985 - 991.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Qvisth, E. Hagstrom-Toft, E. Moberg, S. Sjoberg, and J. Bolinder
Lactate release from adipose tissue and skeletal muscle in vivo: defective insulin regulation in insulin-resistant obese women
Am J Physiol Endocrinol Metab,
March 1, 2007;
292(3):
E709 - E714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bernroider, A. Brehm, M. Krssak, C. Anderwald, Z. Trajanoski, G. Cline, G. I. Shulman, and M. Roden
The Role of Intramyocellular Lipids during Hypoglycemia in Patients with Intensively Treated Type 1 Diabetes
J. Clin. Endocrinol. Metab.,
October 1, 2005;
90(10):
5559 - 5565.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. B. Olsen, M. Sacchetti, F. Dela, T. Ploug, and B. Saltin
Glucose clearance is higher in arm than leg muscle in type 2 diabetes
J. Physiol.,
June 1, 2005;
565(2):
555 - 562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sacchetti, B. Saltin, D. B Olsen, and G. van Hall
High triacylglycerol turnover rate in human skeletal muscle
J. Physiol.,
December 15, 2004;
561(3):
883 - 891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Qvisth, E. Hagstrom-Toft, S. Enoksson, R. S. Sherwin, S. Sjoberg, and J. Bolinder
Combined Hyperinsulinemia and Hyperglycemia, But Not Hyperinsulinemia Alone, Suppress Human Skeletal Muscle Lipolytic Activity in Vivo
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4693 - 4700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schoelch, J. Kuhlmann, M. Gossel, G. Mueller, C. Neumann-Haefelin, U. Belz, J. Kalisch, G. Biemer-Daub, W. Kramer, H.-P. Juretschke, et al.
Characterization of Adenosine-A1 Receptor-Mediated Antilipolysis in Rats by Tissue Microdialysis, 1H-Spectroscopy, and Glucose Clamp Studies
Diabetes,
July 1, 2004;
53(7):
1920 - 1926.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. C. C. Navegantes, M. Sjostrand, S. Gudbjornsdottir, L. Strindberg, M. Elam, and P. Lonnroth
Regulation and Counterregulation of Lipolysis in Vivo: Different Roles of Sympathetic Activation and Insulin
J. Clin. Endocrinol. Metab.,
November 1, 2003;
88(11):
5515 - 5520.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Diabetes Association.
|
|
| |
|